Dr_Cog

You'd be correct! The new anti-amyloid drugs are very exciting, and it makes my work on preclinical Alzheimer's even more fulfilling as it can have a real impact on getting people tested and treated as early as possible.

I'm a research professor of neurology, and my research focuses on developing novel cognitive assessments for measuring early-stage Alzheimer's disease and other types of dementia.